Atomoxetine, formerly sold under the brand name Strattera, was a widely used non-stimulant medication for treating attention-deficit/hyperactivity disorder (ADHD). Unlike stimulant-based ADHD treatments, atomoxetine was often preferred for its lower risk of abuse and was considered a non-habit-forming option.
However, as of November 2023, Eli Lilly and Company officially discontinued all strengths of Strattera from the market. While generic versions of atomoxetine remain available, the brand’s removal has raised concerns for current and former users, particularly those who may be struggling with misuse or are concerned about abrupt changes in their treatment plan.
Although atomoxetine is not classified as addictive in the traditional sense, psychological dependence and patterns of misuse can still develop. When left unaddressed, this may lead to serious health consequences and, in some cases, addiction.
The good news is that atomoxetine misuse and addiction are treatable with the right support. Recognizing the warning signs, side effects, and behavioral changes associated with misuse is the first step toward getting help.
In this guide, we’ll explore the potential for atomoxetine addiction, the side effects of misuse, and how to identify problematic use in yourself or someone you care about. Whether you’re seeking information for yourself or a loved one, understanding the risks and treatment options can help you make informed, compassionate choices moving forward.
